Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia
- PMID: 23675346
- PMCID: PMC3648692
- DOI: 10.3389/fnagi.2013.00019
Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia
Abstract
Considerable evidence implicates hypoxia and vascular inflammation in Alzheimer's disease (AD). Thrombin, a multifunctional inflammatory mediator, is demonstrable in the brains of AD patients both in the vessel walls and senile plaques. Hypoxia-inducible factor 1α (HIF-1α), a key regulator of the cellular response to hypoxia, is also upregulated in the vasculature of human AD brains. The objective of this study is to investigate inflammatory protein expression in the cerebrovasculature of transgenic AD mice and to explore the role of thrombin as a mediator of cerebrovascular inflammation and oxidative stress in AD and in hypoxia-induced changes in brain endothelial cells. Immunofluorescent analysis of the cerebrovasculature in AD mice demonstrates significant (p < 0.01-0.001) increases in thrombin, HIF-1α, interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), matrix metalloproteinases (MMPs), and reactive oxygen species (ROS) compared to controls. Administration of the thrombin inhibitor dabigatran (100 mg/kg) to AD mice for 34 weeks significantly decreases expression of inflammatory proteins and ROS. Exposure of cultured brain endothelial cells to hypoxia for 6 h causes an upregulation of thrombin, HIF-1α, MCP-1, IL-6, and MMP2 and ROS. Treatment of endothelial cells with the dabigatran (1 nM) reduces ROS generation and inflammatory protein expression (p < 0.01-0.001). The data demonstrate that inhibition of thrombin in culture blocks the increase in inflammatory protein expression and ROS generation evoked by hypoxia. Also, administration of dabigatran to transgenic AD mice diminishes ROS levels in brain and reduces cerebrovascular expression of inflammatory proteins. Taken together, these results suggest that inhibiting thrombin generation could have therapeutic value in AD and other disorders where hypoxia, inflammation, and oxidative stress are involved.
Keywords: Alzheimer's disease; dabigatran; endothelial cells; hypoxia; neuroinflammation; thrombin.
Figures




Similar articles
-
Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.J Alzheimers Dis. 2021;79(1):211-224. doi: 10.3233/JAD-200658. J Alzheimers Dis. 2021. PMID: 33252072
-
p38 MAPK: a mediator of hypoxia-induced cerebrovascular inflammation.J Alzheimers Dis. 2012;32(3):587-97. doi: 10.3233/JAD-2012-120829. J Alzheimers Dis. 2012. PMID: 22886009
-
Brain microvasculature and hypoxia-related proteins in Alzheimer's disease.Int J Clin Exp Pathol. 2011 Aug 15;4(6):616-27. Epub 2011 Jun 18. Int J Clin Exp Pathol. 2011. PMID: 21904637 Free PMC article.
-
Targeting thrombin: an inflammatory neurotoxin in Alzheimer's disease.J Alzheimers Dis. 2014;42 Suppl 4:S537-44. doi: 10.3233/JAD-141557. J Alzheimers Dis. 2014. PMID: 25079808 Review.
-
Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer's Disease.Front Neurosci. 2020 Jul 24;14:762. doi: 10.3389/fnins.2020.00762. eCollection 2020. Front Neurosci. 2020. PMID: 32792902 Free PMC article. Review.
Cited by
-
Thrombin aggravates hypoxia/reoxygenation injury of astrocytes by activating the autophagy pathway mediated by SPRED2.Exp Ther Med. 2021 Oct;22(4):1107. doi: 10.3892/etm.2021.10541. Epub 2021 Aug 3. Exp Ther Med. 2021. PMID: 34504561 Free PMC article.
-
Antioxidant Properties of Oral Antithrombotic Therapies in Atherosclerotic Disease and Atrial Fibrillation.Antioxidants (Basel). 2023 May 30;12(6):1185. doi: 10.3390/antiox12061185. Antioxidants (Basel). 2023. PMID: 37371915 Free PMC article. Review.
-
Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse model.Biochem Biophys Rep. 2020 Nov 19;24:100862. doi: 10.1016/j.bbrep.2020.100862. eCollection 2020 Dec. Biochem Biophys Rep. 2020. PMID: 33294639 Free PMC article.
-
Proteasomal degradation of O-GlcNAc transferase elevates hypoxia-induced vascular endothelial inflammatory response†.Cardiovasc Res. 2014 Jul 1;103(1):131-9. doi: 10.1093/cvr/cvu116. Epub 2014 Apr 29. Cardiovasc Res. 2014. PMID: 24788415 Free PMC article.
-
Thrombin regulation of synaptic transmission and plasticity: implications for health and disease.Front Cell Neurosci. 2015 Apr 21;9:151. doi: 10.3389/fncel.2015.00151. eCollection 2015. Front Cell Neurosci. 2015. PMID: 25954157 Free PMC article. Review.
References
-
- Akiyama H., Ikeda K., Kondo H., McGeer P. L. (1992). Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146, 152–154 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous